Breaking News

Quay Opens Packing and Distribution Facility

March 19, 2013

Will support clinical trials from Deeside headquarters

Quay Pharma is expanding its services to support clinical trials with the establishment of a dedicated packing and distribution facility at its Deeside headquarters. The new MHRA-approved area allows Quay to provide both bulk delivery of product and to meet increasing demands for just-in-time deliveries to support randomized and blinded studies.
 
Quay offers the filling of primary packs including bottles, tubes, blister packs, sachets and oral dosing syringes, followed by secondary packing. The company offers multi-language labeling, blinding and randomization and, though its sister company, Chester Medical, can provide individually designed patient packs. Quay also supports cold chain management, including shipping and storage. The inclusion of tamper-evident seals and code break labels can be incorporated as part of the packing process.
 
“Quay has developed this service to assist a number of our clients for whom we have developed products, as they move through to Phase II and Phase III clinical trials,” said Quay Pharma chief executive Maireadh Pedersen. “This is an important enhancement to our client offering, enabling us to continue to support our customers throughout their development phase.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important